← FDA Drug Approvals (Drugs@FDA)
BORTEZOMIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RELIANCE LIFE SCI · Approved 2022-10-11
Drug application
- FDA Application #
ANDA211898- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BORTEZOMIB
- Generic name
- BORTEZOMIB
- Active ingredients
- BORTEZOMIB
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- RELIANCE LIFE SCI
- Manufacturer
- Somerset Therapeutics LLC
- First approval
- 2022-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown